Oppenheimer Upgrades Endologix (ELGX) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
JPMorgan Upgrades Endologix (ELGX) to Overweight
August 6, 2015 6:46 AM EDTJPMorgan upgraded Endologix (NASDAQ: ELGX) from Neutral to Overweight with a price target of $17.00.
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $12.05 yesterday.
... More


